Expression of stem cell marker musashi-1 and its relationship with survival prognosis in patients with resectable esophageal squamous cell carcinoma

doi:10.4252/wjsc.v17.i8.107013

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (14)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

HTML

Figures (1-3)

Tables (1-3)

Sum=14

Aug 26, 2025 (publication date) through Aug 21, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Stem Cells. Aug 26, 2025; 17(8): 107013
Published online Aug 26, 2025. doi: 10.4252/wjsc.v17.i8.107013

Expression of stem cell marker musashi-1 and its relationship with survival prognosis in patients with resectable esophageal squamous cell carcinoma

Ya-Xuan Niu, Min Hu, Wei-Feng Zhao, Hong-Jie Yang

Ya-Xuan Niu, Min Hu, Department of Laboratory, Henan Provincial People’s Hospital, Zhengzhou University People’s Hospital, Zhengzhou 450000, Henan Province, China

Wei-Feng Zhao, Hong-Jie Yang, Tumor Center, Henan Provincial People’s Hospital, Zhengzhou 450000, Henan Province, China

Author contributions: Niu YX designed the study; Hu M performed the experiments; Zhao WF and Yang HJ analysed the data; Niu YX, Hu M, Zhao WF, and Yang HJ contributed to editorial changes in the manuscript. All authors read and approved the final manuscript.

Institutional review board statement: This study was approved by the Medical Ethics Committee of Henan Provincial People’s Hospital (Approval No. HXDXB24011), and the study followed the ethical guidelines of the Declaration of Helsinki.

Informed consent statement: Informed consent was obtained from all study participants.

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Data sharing statement: No additional data are available.

Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Ya-Xuan Niu, Technician in Charge, Department of Laboratory, Henan Provincial People’s Hospital, Zhengzhou University People’s Hospital, No. 7 Weiwu Road, Zhengzhou 450000, Henan Province, China. mini209@126.com

Received: March 14, 2025
Revised: April 19, 2025
Accepted: July 11, 2025
Published online: August 26, 2025
Processing time: 161 Days and 0.5 Hours

Core Tip

Core Tip: The expression level of musashi-1 has been found to be closely associated with the treatment efficacy, disease progression, and overall survival of patients with esophageal squamous cell carcinoma. As a key regulator involved in tumorigenesis and cancer stem cell maintenance, musashi-1 holds promise as a novel biomarker for predicting therapeutic response and assessing long-term prognosis in esophageal squamous cell carcinoma patients, potentially guiding personalized treatment strategies.